'Breaking the bureaucracy': Drug registration and neocolonial relations in Egypt

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

According to the Egyptian Ministry of Health, the per capita use of prescription drugs in Egypt is amongst the highest in the world. Multinational pharmaceutical companies license their proprietary products for manufacture and sale in Egypt through their Egyptian subsidiaries. A Ministry of Health Committee reviews and approves for sale all drugs marketed in the country. Aside from being an extremely lucrative market itself, approval of a drug for sale and manufacture in Egypt also opens to the pharmaceutical companies other markets in the Arab world. The Egyptian drug approval process is thus both important for assuring the health of Egyptian nationals and a high-stakes activity for the pharmaceutical companies. This paper examines the social relations and interactions of multinational pharmaceutical representatives in Egypt with Egyptian researchers in relation to the Ministry of Health's drug approval process. From time-to-time events focus attention on the huge financial rewards reaped by multinational pharmaceutical companies from their activities in lesser developed countries. This attention not infrequently has revealed the 'drugging of the Third World' as a result of actions by expatriate multinational pharmaceutical officials. Indigenous review procedures such as those established by the Egyptian Ministry of Health might guard against such external exploitation. This paper shows how in place of external exploitation, indigenous pharmaceutical company officials have manipulated local patterns of social interaction to construct a system of reciprocal obligations which may frustrate intended safeguards, and by reconstructing colonial institutional structures, creates a pattern of neocolonialism in Egypt.

Original languageEnglish (US)
Pages (from-to)1487-1494
Number of pages8
JournalSocial Science and Medicine
Volume46
Issue number11
DOIs
StatePublished - Jan 1 1998

Fingerprint

bureaucracy
Egypt
pharmaceutical
drug
ministry
Drug Approval
Pharmaceutical Preparations
sale
health
Health
Interpersonal Relations
exploitation
neocolonialism
Arab World
market
interaction
Prescription Drugs
registration
Bureaucracy
Pharmaceuticals

Keywords

  • Drug policy
  • Egypt
  • Neocolonialism
  • Pharmaceutical companies

ASJC Scopus subject areas

  • Economics and Econometrics
  • Public Health, Environmental and Occupational Health
  • Social Psychology
  • Development
  • Health(social science)

Cite this

'Breaking the bureaucracy' : Drug registration and neocolonial relations in Egypt. / Rubinstein, Robert A.

In: Social Science and Medicine, Vol. 46, No. 11, 01.01.1998, p. 1487-1494.

Research output: Contribution to journalArticle

@article{f5f6f6fe11144bee91838d27690f690b,
title = "'Breaking the bureaucracy': Drug registration and neocolonial relations in Egypt",
abstract = "According to the Egyptian Ministry of Health, the per capita use of prescription drugs in Egypt is amongst the highest in the world. Multinational pharmaceutical companies license their proprietary products for manufacture and sale in Egypt through their Egyptian subsidiaries. A Ministry of Health Committee reviews and approves for sale all drugs marketed in the country. Aside from being an extremely lucrative market itself, approval of a drug for sale and manufacture in Egypt also opens to the pharmaceutical companies other markets in the Arab world. The Egyptian drug approval process is thus both important for assuring the health of Egyptian nationals and a high-stakes activity for the pharmaceutical companies. This paper examines the social relations and interactions of multinational pharmaceutical representatives in Egypt with Egyptian researchers in relation to the Ministry of Health's drug approval process. From time-to-time events focus attention on the huge financial rewards reaped by multinational pharmaceutical companies from their activities in lesser developed countries. This attention not infrequently has revealed the 'drugging of the Third World' as a result of actions by expatriate multinational pharmaceutical officials. Indigenous review procedures such as those established by the Egyptian Ministry of Health might guard against such external exploitation. This paper shows how in place of external exploitation, indigenous pharmaceutical company officials have manipulated local patterns of social interaction to construct a system of reciprocal obligations which may frustrate intended safeguards, and by reconstructing colonial institutional structures, creates a pattern of neocolonialism in Egypt.",
keywords = "Drug policy, Egypt, Neocolonialism, Pharmaceutical companies",
author = "Rubinstein, {Robert A}",
year = "1998",
month = "1",
day = "1",
doi = "10.1016/S0277-9536(97)10147-2",
language = "English (US)",
volume = "46",
pages = "1487--1494",
journal = "Social Science and Medicine",
issn = "0277-9536",
publisher = "Elsevier",
number = "11",

}

TY - JOUR

T1 - 'Breaking the bureaucracy'

T2 - Drug registration and neocolonial relations in Egypt

AU - Rubinstein, Robert A

PY - 1998/1/1

Y1 - 1998/1/1

N2 - According to the Egyptian Ministry of Health, the per capita use of prescription drugs in Egypt is amongst the highest in the world. Multinational pharmaceutical companies license their proprietary products for manufacture and sale in Egypt through their Egyptian subsidiaries. A Ministry of Health Committee reviews and approves for sale all drugs marketed in the country. Aside from being an extremely lucrative market itself, approval of a drug for sale and manufacture in Egypt also opens to the pharmaceutical companies other markets in the Arab world. The Egyptian drug approval process is thus both important for assuring the health of Egyptian nationals and a high-stakes activity for the pharmaceutical companies. This paper examines the social relations and interactions of multinational pharmaceutical representatives in Egypt with Egyptian researchers in relation to the Ministry of Health's drug approval process. From time-to-time events focus attention on the huge financial rewards reaped by multinational pharmaceutical companies from their activities in lesser developed countries. This attention not infrequently has revealed the 'drugging of the Third World' as a result of actions by expatriate multinational pharmaceutical officials. Indigenous review procedures such as those established by the Egyptian Ministry of Health might guard against such external exploitation. This paper shows how in place of external exploitation, indigenous pharmaceutical company officials have manipulated local patterns of social interaction to construct a system of reciprocal obligations which may frustrate intended safeguards, and by reconstructing colonial institutional structures, creates a pattern of neocolonialism in Egypt.

AB - According to the Egyptian Ministry of Health, the per capita use of prescription drugs in Egypt is amongst the highest in the world. Multinational pharmaceutical companies license their proprietary products for manufacture and sale in Egypt through their Egyptian subsidiaries. A Ministry of Health Committee reviews and approves for sale all drugs marketed in the country. Aside from being an extremely lucrative market itself, approval of a drug for sale and manufacture in Egypt also opens to the pharmaceutical companies other markets in the Arab world. The Egyptian drug approval process is thus both important for assuring the health of Egyptian nationals and a high-stakes activity for the pharmaceutical companies. This paper examines the social relations and interactions of multinational pharmaceutical representatives in Egypt with Egyptian researchers in relation to the Ministry of Health's drug approval process. From time-to-time events focus attention on the huge financial rewards reaped by multinational pharmaceutical companies from their activities in lesser developed countries. This attention not infrequently has revealed the 'drugging of the Third World' as a result of actions by expatriate multinational pharmaceutical officials. Indigenous review procedures such as those established by the Egyptian Ministry of Health might guard against such external exploitation. This paper shows how in place of external exploitation, indigenous pharmaceutical company officials have manipulated local patterns of social interaction to construct a system of reciprocal obligations which may frustrate intended safeguards, and by reconstructing colonial institutional structures, creates a pattern of neocolonialism in Egypt.

KW - Drug policy

KW - Egypt

KW - Neocolonialism

KW - Pharmaceutical companies

UR - http://www.scopus.com/inward/record.url?scp=0031800226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031800226&partnerID=8YFLogxK

U2 - 10.1016/S0277-9536(97)10147-2

DO - 10.1016/S0277-9536(97)10147-2

M3 - Article

C2 - 9665578

AN - SCOPUS:0031800226

VL - 46

SP - 1487

EP - 1494

JO - Social Science and Medicine

JF - Social Science and Medicine

SN - 0277-9536

IS - 11

ER -